E5204 – Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation

Physician and Research Staff Educational Materials:

These materials are intended for promotional use among health care professionals and are NOT intended for use as patient educational materials.

  • Slide Presentation: trial rationale, schema, objectives, statistical design, eligibility criteria, treatment plan, trial endpoints, long-term follow-up, and ancillary studies.
  • Pocket Reference Card: trial schema, study objectives, and eligibility requirements on a pocket-sized card for easy reference when consulting with patients in the office or on rounds.

Patient Educational Materials:

  • Patient FAQs: frequently asked questions from patients about treatment, eligibility criteria, and potential enrollment issues, with answers in lay language.

Additional Information at ClinicalTrials.gov:

NCT00303628